ES505801A0 - Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina. - Google Patents

Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina.

Info

Publication number
ES505801A0
ES505801A0 ES505801A ES505801A ES505801A0 ES 505801 A0 ES505801 A0 ES 505801A0 ES 505801 A ES505801 A ES 505801A ES 505801 A ES505801 A ES 505801A ES 505801 A0 ES505801 A0 ES 505801A0
Authority
ES
Spain
Prior art keywords
benzofuranil
tanolamine
derivative
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES505801A
Other languages
English (en)
Other versions
ES8303394A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8303394A1 publication Critical patent/ES8303394A1/es
Publication of ES505801A0 publication Critical patent/ES505801A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES505801A 1980-09-26 1981-09-25 Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina. Granted ES505801A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031228 1980-09-26

Publications (2)

Publication Number Publication Date
ES8303394A1 ES8303394A1 (es) 1983-02-01
ES505801A0 true ES505801A0 (es) 1983-02-01

Family

ID=10516329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505801A Granted ES505801A0 (es) 1980-09-26 1981-09-25 Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina.

Country Status (12)

Country Link
US (1) US4432993A (es)
EP (1) EP0051917B1 (es)
JP (1) JPS5785383A (es)
AU (1) AU546104B2 (es)
CA (1) CA1175851A (es)
DE (1) DE3173816D1 (es)
ES (1) ES505801A0 (es)
GR (1) GR75048B (es)
IE (1) IE52076B1 (es)
NZ (1) NZ198389A (es)
PT (1) PT73712B (es)
ZA (1) ZA816567B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8615995D0 (en) * 1986-07-01 1986-08-06 Glaxo Group Ltd Veterinary preparations
GB8707122D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
US5151439A (en) * 1990-05-04 1992-09-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
AT395849B (de) * 1991-04-04 1993-03-25 Noe Christian R Pharmakologisch aktive in position 3 substituierte alpha-aminomethyl-2benzofuranmethanole
AU675536B2 (en) * 1993-06-14 1997-02-06 Pfizer Inc. Secondary amines as antidiabetic and antiobesity agents
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5627200A (en) * 1994-09-26 1997-05-06 Pfizer Inc β3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
DE69711519T2 (de) 1996-09-05 2002-10-31 Eli Lilly And Co., Indianapolis Carbazolanaloge als selektive beta3-adrenergische Agonisten
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
US20040018959A1 (en) * 2002-05-02 2004-01-29 Randall S. Hickle System and methods of lipid removal from the body

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE663926A (es) * 1964-05-20
US3929836A (en) * 1965-05-11 1975-12-30 Hoffmann La Roche 2-(2-Lower alkylamino-1-hydroxy-ethyl)-substituted benzofurans
GB1472959A (en) * 1974-09-26 1977-05-11 Roche Products Ltd Benzofuran derivatives and a process for the manufacture thereof
GB1509300A (en) * 1975-12-05 1978-05-04 Ici Ltd Ethanolamine derivatives
DE2946058A1 (de) * 1979-11-15 1981-05-21 I.P.U. Ltd., Nassau Feuerschutzabschlussvorrichtung

Also Published As

Publication number Publication date
ES8303394A1 (es) 1983-02-01
GR75048B (es) 1984-07-12
EP0051917A1 (en) 1982-05-19
ZA816567B (en) 1982-09-29
PT73712A (en) 1981-10-01
AU546104B2 (en) 1985-08-15
NZ198389A (en) 1984-03-30
EP0051917B1 (en) 1986-02-19
IE812231L (en) 1982-03-26
AU7560381A (en) 1982-04-01
IE52076B1 (en) 1987-06-10
PT73712B (en) 1982-12-30
CA1175851A (en) 1984-10-09
DE3173816D1 (en) 1986-03-27
US4432993A (en) 1984-02-21
JPS5785383A (en) 1982-05-28

Similar Documents

Publication Publication Date Title
ES519032A0 (es) Un procedimiento para preparar derivados de fenilciclobutano.
ES507332A0 (es) Un procedimiento para preparar derivados de nicotinamida.
AR231533A1 (es) Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida
MX8481A (es) Procedimiento para preparar compuestos de carboestirilo.
ES518276A0 (es) Un procedimiento para preparar nuevos derivados de tienopirimidina.
ES505801A0 (es) Un procedimiento para preparar un derivado de 2-(2-benzofuranil) e tanolamina.
ES519331A0 (es) Procedimiento para preparar un compuesto de 2-(fenilmetilen) cicloalquilaminas y -azetidinas.
ES519006A0 (es) Procedimiento para preparar 2-(2-dimetilaminoetiltio)-3-fenilquinolina.
ES499504A0 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES503134A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES507755A0 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
ES505498A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES505656A0 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
ES502153A0 (es) Un procedimiento para la preparacion de compuestos n-acil-n- (cicloalquil) aminoacidos.
ES521361A0 (es) Un metodo para preparar un derivado 14-acilico de lankacidina.
ES507975A0 (es) Un metodo para preparar derivados de pirazolina.
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES500478A0 (es) Un procedimiento para obtener derivados de biciclooctano
ES501534A0 (es) Un procedimiento para la preparacion de derivado de bis-hidroxibencilo.
ES505886A0 (es) Un procedimiento para obtener nuevos compuestos de beta-lac-tama
ES505714A0 (es) Un procedimiento para preparar compuestos de cefem
ES518580A0 (es) Un procedimiento para preparar un derivado de aminopropilaminobleomicina.
ES520407A0 (es) Un procedimiento para preparar un derivado de 3-azetidiniletil-1-fenil-2-imidazolidinona.
ES517996A0 (es) Un procedimiento para preparacion de 2-(2-piridila cetil)-p-anisanilida.